Compile Data Set for Download or QSAR
maximum 50k data
Found 52 with Last Name = 'sørensen' and Initial = 'md'
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130938(US8829190, 116)
Affinity DataIC50:  0.100nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130937(US8829190, 115)
Affinity DataIC50:  0.200nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130939(US8829190, 117)
Affinity DataIC50:  0.200nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130933(US8829190, 111)
Affinity DataIC50:  0.300nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130936(US8829190, 114)
Affinity DataIC50:  0.400nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130932(US8829190, 110)
Affinity DataIC50:  0.5nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130935(US8829190, 113)
Affinity DataIC50:  0.700nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130934(US8829190, 112)
Affinity DataIC50:  1nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130923(US8829190, 101)
Affinity DataIC50:  2nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130950(US8829190, 128)
Affinity DataIC50:  3nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130940(US8829190, 118)
Affinity DataIC50:  3nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136890(CHEMBL152208 | [2-Chloro-4-(4-fluoro-2-methyl-phen...)
Affinity DataIC50:  4nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130928(US8829190, 106)
Affinity DataIC50:  4nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136887(CHEMBL356455 | [4-(2-Amino-phenylamino)-2-chloro-p...)
Affinity DataIC50:  5nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130925(US8829190, 103)
Affinity DataIC50:  7nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136897((2-Chloro-4-phenylamino-phenyl)-o-tolyl-methanone ...)
Affinity DataIC50:  7nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130941(US8829190, 119)
Affinity DataIC50:  8nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136886(CHEMBL152767 | [4-(2-Amino-phenylamino)-2-chloro-p...)
Affinity DataIC50:  10nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136884((2-Chloro-4-o-tolylamino-phenyl)-o-tolyl-methanone...)
Affinity DataIC50:  12nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136898(CHEMBL152820 | [4-(2-Amino-phenylamino)-2-methyl-p...)
Affinity DataIC50:  13nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136900(1-{2-[3-Chloro-4-(2-methyl-benzoyl)-phenylamino]-p...)
Affinity DataIC50:  21nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130931(US8829190, 109)
Affinity DataIC50:  24nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130926(US8829190, 104)
Affinity DataIC50:  26nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136903(CHEMBL357732 | [4-(2-Amino-phenylamino)-phenyl]-o-...)
Affinity DataIC50:  29nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM15244(5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfa...)
Affinity DataIC50:  29nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50099331(4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidaz...)
Affinity DataIC50:  38nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136885(CHEMBL347496 | [4-(2-Amino-4-bromo-phenylamino)-2-...)
Affinity DataIC50:  39nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136888(CHEMBL153012 | {2-[3-Chloro-4-(2-methyl-benzoyl)-p...)
Affinity DataIC50:  42nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130929(US8829190, 107)
Affinity DataIC50:  45nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130949(US8829190, 127)
Affinity DataIC50:  46nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130946(US8829190, 124)
Affinity DataIC50:  52nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136899(CHEMBL152440 | [4-(2-Amino-phenylamino)-phenyl]-(2...)
Affinity DataIC50:  54nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130930(US8829190, 108)
Affinity DataIC50:  55nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136901(CHEMBL422510 | N-{2-[3-Chloro-4-(2-methyl-benzoyl)...)
Affinity DataIC50:  63nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130945(US8829190, 123)
Affinity DataIC50:  68nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136895(CHEMBL347770 | {4-[(2-Amino-phenyl)-methyl-amino]-...)
Affinity DataIC50:  101nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130924(US8829190, 102)
Affinity DataIC50:  134nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136902(CHEMBL155448 | [4-(2-Amino-phenylamino)-2-chloro-p...)
Affinity DataIC50:  139nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136896(CHEMBL356157 | [4-(2-Amino-phenylamino)-3-methyl-p...)
Affinity DataIC50:  143nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136882(CHEMBL152596 | [4-(2-Amino-phenylamino)-phenyl]-ph...)
Affinity DataIC50:  145nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136891(CHEMBL152349 | Phenyl-(4-phenylamino-phenyl)-metha...)
Affinity DataIC50:  193nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130944(US8829190, 122)
Affinity DataIC50:  261nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130927(US8829190, 105)
Affinity DataIC50:  305nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136883(CHEMBL347576 | [2-Chloro-4-(2-nitro-phenylamino)-p...)
Affinity DataIC50:  437nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130948(US8829190, 126)
Affinity DataIC50:  548nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136893(CHEMBL152209 | [4-(2-Amino-phenylamino)-phenyl]-m-...)
Affinity DataIC50:  574nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136892(CHEMBL356809 | [4-(2-Amino-phenylamino)-phenyl]-bi...)
Affinity DataIC50:  811nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50136889(CHEMBL152403 | N-[3-Chloro-4-(1-o-tolyl-vinyl)-phe...)
Affinity DataIC50:  1.55E+3nMAssay Description:In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alphaMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130942(US8829190, 120)
Affinity DataIC50:  2.50E+3nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130947(US8829190, 125)
Affinity DataIC50:  3.10E+3nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: